spasmodic dysphonia (ABSD) is a rare subtype of focal dystonia involving the larynx. Laryngeal injection of botulinum toxin A was first described in 1988 1 and has since been widely used for symptomatic relief of ABSD.
Retropharyngeal hematoma following botulinum toxin injection for abductor spasmodic dysphonia Joo Koh, MBBS; Sanjay Raghav, MBBS, MD, FRACP; Malcolm Baxter, OAM, MBBS, FRACS Abductor spasmodic dysphonia (ABSD) is a rare subtype of focal dystonia involving the larynx. Laryngeal injection of botulinum toxin A was first described in 1988 1 and has since been widely used for symptomatic relief of ABSD.
In this article we describe a case of an acute complication after botulinum toxin injection for ABSD. Our patient was a 60-year-old nonsmoking woman with a 2-year history of ABSD and a background history of gastroesophageal reflux disease. Her regular medications included omeprazole and fish oil supplements. She attended routine 3-monthly reviews, undergoing botulinum toxin injection for symptomatic management of her ABSD. She had undergone a botulinum toxin Further examination revealed a tender and swollen neck. The symptoms progressively worsened, and the patient subsequently developed stridor. She underwent an awake fibreoptic intubation to secure her airway. During intubation, a large retropharyngeal bulge was visualized on the left side, extending downward into the piriform fossa and beyond. A tracheotomy was performed, followed by a left lateral horizontal neck incision with elevation of a subplatysmal flap. The hematoma was encountered and evacuated after layered dissection medial to the left sternocleidomastoid muscle.
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Intraoperatively, no bleeding vessel was identified, and a corrugated drain tube was inserted before layered closure of the wound.
The patient was admitted to the intensive care unit postoperatively. She made good clinical recovery. The drain tube was removed on postsurgical day 4. She was successfully decannulated on postsurgical day 7 and discharged. On further follow-up at 4 months, the patient had made full recovery from the tracheotomy. Apart from a small tracheotomy wound, she had no residual breathing or swallowing symptoms.
ABSD is characterized by abductor spasms leading to breathy voice breaks or whispering quality, particularly during prolonged voice production. The vocal folds are typically normal at rest. However, upon movement, the muscles contract abnormally, leading to inappropriate movements and subsequently causing dysphonia. Diagnosis is made with FNE of the larynx, which is confirmed with intermittent or persistent vocal fold abduction during prolonged voice production.
Surgical management involving posterior cricoarytenoid myoplasty with medialization thyroplasty has been described as a management option. 2 However, botulinum toxin injection into the posterior cricoarytenoid muscle remains the gold standard of management. This treatment has been reported to provide an improved voice in about 70% of patients, compared with about 91% in patients with adductor spasmodic dysphonia. 1 Thus far, reported side effects of this management option include transient symptoms of sore throat, rash, itch, and dysphagia. 1 No other serious complications have been reported.
To the best of our knowledge, this is first report of retropharyngeal hematoma as an unusual complication of botulinum toxin injection. Otolaryngologists performing this procedure should be mindful of this potential complication and investigate accordingly, particularly if patients report symptoms that do not correlate with clinical findings.
